Nevertheless, another study showed that even though the fertility of Tamoxifen-treated patients with breast cancer was lower than that of those who did not receive treatment, there was a higher AMH level in Tamoxifen-treated women, suggesting no reduction in ovarian reserve (OR) [33]. The gene discussed is AMH; the disease is breast cancer.